Evolent Health (EVH) PT Raised to $9.50 at Goldman Sachs

August 5, 2020 6:28 AM EDT
Get Alerts EVH Hot Sheet
Price: $4.41 -5.77%

Rating Summary:
    20 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Goldman Sachs analyst Robert Jones raised the price target on Evolent Health (NYSE: EVH) to $9.50 (from $8.50) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change